Nuwellis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Nuwellis, Inc. (Nasdaq: NUWE) on October 7, 2025, reporting events occurring on October 7 and October 8, 2025. The filing addresses significant changes in executive leadership regarding the Chief Financial Officer position.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes rather than financial performance.
Material Changes
- Resignation of CFO: Robert B. Scott resigned as Chief Financial Officer effective October 7, 2025, with a separation date expected on or about October 24, 2025. The resignation is not the result of any disagreement with the Company regarding operations, policies, or procedures.
- Appointment of Interim CFO: On October 8, 2025, the Board appointed John L. Erb, the Company's President and Chief Executive Officer, as the interim Chief Financial Officer, interim Principal Financial Officer, and interim Principal Accounting Officer, effective on the Separation Date.
- Search Process: The Company expects to commence a formal search process for a permanent Chief Financial Officer.
Guidance, Outlook, and Management Commentary
Mr. Erb, age 76, brings extensive experience in the medical device sector, having previously served as CEO of Nuwellis (2015-2021), NuAx, Inc., and IntraTherapeutics, Inc. He will not receive additional compensation for assuming the interim roles, and no changes have been made to his existing compensation plans. The filing contains no specific financial guidance, risk factors, or contingencies related to the company's operational outlook.
Investor Verification Checklist
- Confirm the timeline for the formal search for a permanent Chief Financial Officer.
- Monitor future filings for the appointment of a permanent CFO and any associated compensation arrangements.
- Review upcoming quarterly reports (10-Q) or annual reports (10-K) for financial performance data, as this 8-K contains no financial metrics.
- Verify that the transition of financial reporting responsibilities to the CEO does not impact the timing or quality of future financial disclosures.